<p>Bio-Rad Laboratories, Inc.（紐約證券交易所代碼：BIO.B - 獲取免費報告）在週五的交易量有所上升。交易期間共交易了 380 股，較前一交易日的 300 股增加了 27%。該股票最後交易價格為 255.54 美元，之前收盤價為 258.46 美元。</p>
<p>獲取 <strong>Bio-Rad Laboratories</strong> 的提醒：</p>
<h2>Bio-Rad Laboratories 股票下跌 1.1%</h2>
<p>該公司的 50 日移動平均價格為 276.18 美元，200 日移動平均價格為 294.91 美元。公司市值為 69 億美元，市盈率為 42.10，貝塔值為 0.96。公司的債務與股本比率為 0.12，速動比率為 2.37，流動比率為 3.21。</p>
<p>Bio-Rad Laboratories（紐約證券交易所代碼：BIO.B - 獲取免費報告）於 4 月 30 日（星期四）發佈了季度財報。公司報告該季度每股收益為 1.89 美元。Bio-Rad Laboratories 的淨利潤率為 6.52%，股本回報率為 3.56%。</p>
<h2>Bio-Rad Laboratories 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Bio-Rad Laboratories, Inc 是一家全球領先的創新產品和系統提供商，服務於生命科學研究和臨牀診斷市場。該公司通過兩個主要部門運營：生命科學部門，提供用於研究應用的儀器、耗材和軟件；臨牀診斷部門，提供用於血型鑑定、免疫學和分子檢測的質量控制材料和試劑系統。Bio-Rad 的產品組合支持廣泛的應用，包括蛋白質分析、基因表達、細胞生物學和數字 PCR。</p>
<p>在生命科學部門，Bio-Rad 開發和銷售電泳和成像系統、色譜儀器、實驗室耗材和簡化實驗工作流程的軟件平台等技術。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Bio-Rad Laboratories</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Bio-Rad Laboratories 嗎？</h2>
<p>在你考慮 Bio-Rad Laboratories 之前，你需要聽聽這個。</p>
<p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Bio-Rad Laboratories 並不在名單上。</p>
<p>雖然 Bio-Rad Laboratories 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

Bio-Rad實驗室-B

<p>Bio-Rad 實驗室（NYSE:BIO.B）在週五的交易量增加了 27%，共交易了 380 股。股價下跌了 1.1%，至 255.54 美元，較前一交易日的 258.46 美元有所下降。該公司的市值為 69 億美元，市盈率為 42.10，淨利潤率為 6.52%。分析師目前對 Bio-Rad 的評級為持有，但建議其他股票可能是更好的投資選擇</p>

<p>Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) saw an uptick in trading volume on Friday . 380 shares were traded during trading, an increase of 27% from the previous session's volume of 300 shares.The stock last traded at $255.54 and had previously closed at $258.46.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories, Inc.（紐約證券交易所代碼：BIO.B - 獲取免費報告）在週五的交易量有所上升。交易期間共交易了 380 股，較前一交易日的 300 股增加了 27%。該股票最後交易價格為 255.54 美元，之前收盤價為 258.46 美元。</p>
</div><p>Get <strong>Bio-Rad Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Bio-Rad Laboratories</strong> 的提醒：</p>
</div><h2>Bio-Rad Laboratories Stock Down 1.1%</h2>
<div class="lb-trans"><h2>Bio-Rad Laboratories 股票下跌 1.1%</h2>
</div><p>The firm's 50-day moving average price is $276.18 and its two-hundred day moving average price is $294.91. The firm has a market cap of $6.90 billion, a PE ratio of 42.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.37 and a current ratio of 3.21.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均價格為 276.18 美元，200 日移動平均價格為 294.91 美元。公司市值為 69 億美元，市盈率為 42.10，貝塔值為 0.96。公司的債務與股本比率為 0.12，速動比率為 2.37，流動比率為 3.21。</p>
</div><p>Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.89 EPS for the quarter. Bio-Rad Laboratories had a net margin of 6.52% and a return on equity of 3.56%.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories（紐約證券交易所代碼：BIO.B - 獲取免費報告）於 4 月 30 日（星期四）發佈了季度財報。公司報告該季度每股收益為 1.89 美元。Bio-Rad Laboratories 的淨利潤率為 6.52%，股本回報率為 3.56%。</p>
</div><h2>Bio-Rad Laboratories Company Profile</h2>
<div class="lb-trans"><h2>Bio-Rad Laboratories 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad's product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.</p>
<div class="lb-trans"><p>Bio-Rad Laboratories, Inc 是一家全球領先的創新產品和系統提供商，服務於生命科學研究和臨牀診斷市場。該公司通過兩個主要部門運營：生命科學部門，提供用於研究應用的儀器、耗材和軟件；臨牀診斷部門，提供用於血型鑑定、免疫學和分子檢測的質量控制材料和試劑系統。Bio-Rad 的產品組合支持廣泛的應用，包括蛋白質分析、基因表達、細胞生物學和數字 PCR。</p>
</div><p>In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.</p>
<div class="lb-trans"><p>在生命科學部門，Bio-Rad 開發和銷售電泳和成像系統、色譜儀器、實驗室耗材和簡化實驗工作流程的軟件平台等技術。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Bio-Rad Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Bio-Rad Laboratories</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bio-Rad Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Bio-Rad Laboratories 嗎？</h2>
</div><p>Before you consider Bio-Rad Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Bio-Rad Laboratories 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Bio-Rad Laboratories 並不在名單上。</p>
</div><p>While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Bio-Rad Laboratories 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Bio-Rad Lab-B（NYSE:BIO.B）交易量強勁 - 你是否應該購買？